Cargando…
Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation
BACKGROUND: In the recent ESC/EACTS guidelines, left atrial appendage (LAA) occlusion or exclusion in patients undergoing (thoracoscopic) atrial fibrillation (AF) ablation surgery is recommended. The Watchman device (WD, Boston Scientific, Minnesota) has proved to reduce the risk of thromboembolic e...
Autores principales: | Vroomen, Mindy, Maesen, Bart, Luermans, Justin G., Crijns, Harry J., Maessen, Jos G., La Meir, Mark, Pison, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739757/ https://www.ncbi.nlm.nih.gov/pubmed/31772531 http://dx.doi.org/10.1155/2019/4525084 |
Ejemplares similares
-
Epicardial and Endocardial Validation of Conduction Block After Thoracoscopic Epicardial Ablation of Atrial Fibrillation
por: Vroomen, Mindy, et al.
Publicado: (2020) -
Adenosine administration during hybrid atrial fibrillation ablation to test dormant pulmonary vein conduction
por: Vroomen, Mindy, et al.
Publicado: (2017) -
Hybrid thoracoscopic surgical and transvenous catheter ablation versus transvenous catheter ablation in persistent and longstanding persistent atrial fibrillation (HARTCAP-AF): study protocol for a randomized trial
por: Vroomen, Mindy, et al.
Publicado: (2019) -
Successful thoracoscopic clipping of a thrombus-containing left atrial appendage
por: Vroomen, Mindy, et al.
Publicado: (2020) -
Hybrid ablation of atrial fibrillation: A unilateral left‐sided thoracoscopic approach
por: van der Heijden, Claudia A. J., et al.
Publicado: (2022)